Study Probes Pancreatic Cancer Therapy Resistance

Newsfeed Image, Light Gray Text On Dark Gray Background
A University of Nebraska Medical Center (UNMC) researcher has released study findings with regard to pancreatic cancer therapy resistance.
Results of the probe conducted by Pankaj Singh, a UNMC professor in the Eppley Institute for Research in Cancer and Allied Diseases, was published in Cancer Cell.

Poor survival in pancreatic cancer is due in part to modest response to the existing therapies, including mimetics of nucleosides, which get modified and make DNA.
It is estimated the one-year survival rate of people with pancreatic cancer who do not have surgery is 29 percent while the five-year survival rate is 7 percent. Read more . . .

image_printPrint Page